Sophie Hirsch1,2,3,4, Cristiana Roggia5, Saskia Biskup6, Benjamin Bender7, Irina Gepfner-Tuma1,2,3, Franziska Eckert3,8, Daniel Zips3,8, Nisar P Malek4,9, Helmut Wilhelm10, Mirjam Renovanz11, Ghazaleh Tabatabai1,2,3.
Abstract
No abstract available
- Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
- Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.
- Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
- Center for Personalized Medicine, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
- Department of Genetics, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
- CeGaT and Praxis for Human Genetics, Tübingen, Germany.
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
- Department of Radiation Oncology, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
- Department of Internal Medicine I, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
- Department of Ophtalmology, Division of Neuro-ophtalmology, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
- Department of Neurosurgery, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.